FMC Corporation

FMC Corporation Submits Regulatory Dossier for Rimisoxafen, the Industry's First Dual Mode of Action Herbicide, in Brazil

FMC Corporation submitted the regulatory dossier for rimisoxafen to Brazilian authorities, its second global filing after the July 2026 U.S. EPA submission. Rimisoxafen is billed as the industry's first dual mode of action herbicide (HRAC Groups 12 and 32), targeting resistant broadleaf weeds across Brazil's roughly 70 million hectares of corn and soybeans. It is the third novel herbicide active ingredient FMC has advanced in Brazil, following Isoflex™ active and Dodhylex™ active; the product is not yet registered for sale and outcomes remain subject to regulatory review.

•1mo ago

From Lab to Three Continents: AgroSpheres and FMC Corporation Advance Bioinsecticide Pipeline Into Global Field Trials

FMC Corporation and AgroSpheres are advancing two proprietary RNA-based bioinsecticide candidates into full-scale global field trials across the United States, Brazil and Asia, a milestone in the collaboration the companies first announced in 2024. The candidates target some of the world's most damaging lepidopteran pests -- including fall armyworm and diamondback moth -- which cause nearly $14 billion in global crop losses and control costs annually. The biomolecules are delivered via AgroSpheres' AgriCell encapsulation platform, which protects actives from UV, heat and moisture and enables targeted release; the candidates reportedly met or exceeded industry-standard chemistries in lab, greenhouse and small-plot testing before advancing. For FMC this is an early-stage R&D milestone with no disclosed financial terms or commercial timeline -- a pipeline option rather than near-term revenue driver.

•1mo ago

FMC Corporation Declares Quarterly Dividend

FMC Corporation's board of directors declared a regular quarterly dividend of 8 cents per share. The dividend is payable on October 15, 2026, to shareholders of record as of the close of business on September 30, 2026.

•3mo ago

FMC Corporation Files First Global Regulatory Submission for Rimisoxafen with United States Environmental Protection Agency

FMC Corporation submitted the regulatory dossier for rimisoxafen to the U.S. Environmental Protection Agency, marking the first global submission for this novel active ingredient. Rimisoxafen is the first herbicide classified as a dual mode of action by the Global Herbicide Resistance Action Committee, utilizing Groups 12 and 32 to delay resistance development in corn, soybeans, sunflowers, and pulse crops. The submission highlights FMC's R&D productivity, representing the third novel herbicide active ingredient advanced to regulatory review in recent years amidst a U.S. market spending over $6 billion annually on weed control.

•4mo ago

FMC Corporation Reaches Agreement for $400 Million Minority Equity Investment from Tessenderlo Group

FMC agreed to a $400 million strategic minority investment from Tessenderlo Group at $13.30 per share, giving Tessenderlo a 20% stake and concluding FMC's strategic options review. FMC intends to use the proceeds to pay down debt, reaching its approximately $1 billion leverage reduction target while continuing operations as an independent company. The deal follows months of balance sheet actions, including a $1.2 billion high-yield bond offering, asset sales totaling over $500 million, and covenant relief on its credit facility.

•4mo ago

FMC Corporation Announces $114 Million Sale-Leaseback of Newark, Delaware Property

FMC Corporation entered into a framework agreement to sell its Newark, Delaware property for gross proceeds of approximately $114 million. The company intends to lease back the facilities, including its global R&D headquarters at the Stine Research Center, and apply proceeds directly to debt reduction. The transaction is expected to close in the fourth quarter of 2026, subject to a due diligence period and finalization of leaseback terms.

•4mo ago

FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology

Corteva and FMC entered a co-exclusive supply and license agreement for the rimisoxafen herbicide technology across North and South American corn and soybean markets. Corteva will make an initial prepurchase payment of $200 million to FMC for the product supply under the decade-long agreement aimed at controlling herbicide-resistant weeds. First commercial sales of the dual mode of action herbicide are anticipated by the end of the decade pending regulatory approvals, addressing key resistance challenges like Palmer amaranth.

•4mo ago

FMC Corporation Announces Agreement to Divest India Commercial Business to Crystal Crop Protection Limited

FMC Corporation agreed to sell its India commercial business, FMC India Private Limited, to Crystal Crop Protection Limited for $252 million. The transaction, expected to close by year-end 2026, allows FMC to focus resources on higher-growth opportunities and allocate all proceeds to debt reduction. FMC will retain R&D and manufacturing operations in India and has signed a preferred supply agreement with Crystal Crop Protection for active ingredients.

•6mo ago

FMC Corporation reports first quarter 2026 results above guidance with Adjusted EBITDA above high end of range, reaffirms full-year outlook

FMC reported Q1 revenue of $759 million, down 4% year-over-year, while Adjusted EBITDA of $72 million exceeded the high end of guidance despite a 40% decline from the prior year. The company reaffirmed its full-year 2026 outlook, projecting revenue of $3.60B to $3.80B and Adjusted EBITDA of $670M to $730M, with expectations for improved free cash flow. Management highlighted progress on its 'Project Foundation' restructuring plan and approximately $1 billion in targeted debt reduction, while the Board-authorized strategic alternatives review continues.

•6mo ago